demonstrated that AML blasts could induce KLRG-1 and CD57 expression on CD8+ T cells ex-vivo and was associated with unresponsiveness to PD-1 blockade in AML (21). This evidence concerns the gene B3GAT1 and acute myeloid leukemia.